- Home
- MAMA vs ZURA Comparison
MAMA vs ZURA Comparison
Compare MAMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- ZURA
- Stock Information
- Founded
- MAMA 2010
- ZURA 2022
- Country
- MAMA United States
- ZURA United States
- Employees
- MAMA N/A
- ZURA N/A
- Industry
- MAMA Specialty Foods
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- ZURA Health Care
- Exchange
- MAMA Nasdaq
- ZURA Nasdaq
- Market Cap
- MAMA 290.7M
- ZURA 292.1M
- IPO Year
- MAMA N/A
- ZURA N/A
- Fundamental
- Price
- MAMA $9.17
- ZURA $2.88
- Analyst Decision
- MAMA Strong Buy
- ZURA Buy
- Analyst Count
- MAMA 4
- ZURA 6
- Target Price
- MAMA $10.00
- ZURA $15.80
- AVG Volume (30 Days)
- MAMA 267.1K
- ZURA 390.6K
- Earning Date
- MAMA 12-10-2024
- ZURA 11-07-2024
- Dividend Yield
- MAMA N/A
- ZURA N/A
- EPS Growth
- MAMA N/A
- ZURA N/A
- EPS
- MAMA 0.13
- ZURA N/A
- Revenue
- MAMA $113,593,000.00
- ZURA N/A
- Revenue This Year
- MAMA $18.91
- ZURA N/A
- Revenue Next Year
- MAMA $12.69
- ZURA N/A
- P/E Ratio
- MAMA $70.20
- ZURA N/A
- Revenue Growth
- MAMA 17.81
- ZURA N/A
- 52 Week Low
- MAMA $3.46
- ZURA $2.00
- 52 Week High
- MAMA $9.98
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- MAMA 57.15
- ZURA 36.44
- Support Level
- MAMA $7.65
- ZURA $2.71
- Resistance Level
- MAMA $9.98
- ZURA $2.87
- Average True Range (ATR)
- MAMA 0.45
- ZURA 0.23
- MACD
- MAMA 0.05
- ZURA -0.01
- Stochastic Oscillator
- MAMA 65.24
- ZURA 31.51
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.